Cat /

Breed profile · FDA CVM July 2026 extract

Bombay adverse-event record

Adverse-event filings for Bombay (Cat) in the FDA Center for Veterinary Medicine openFDA extract. Browse cat breeds, reactions, and outcomes below.

#226 of 510
by report volume (all breeds)
116
FDA CVM reports on file
7.8%
death-coded share of reports
#72 of 275
by death-coded share (≥50 reports)

How the 116 reports break down

By recorded gender -- every report on file for Bombay, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 23 17.25 11.5 5.75 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Bombay drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Bombay ranks #226 of 510 by total reports (116) and #72 of 275 by death-coded share (7.8%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#226
This breed, reports of 510
#72
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Bombay has 116 reports now versus 112 in that prior snapshot: 4 more (3.6%).

Report change
+4
Death-coded reports
+0
Death-coded share
−0.3 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Bombay changes

Total Reports

116

Above-median volume

Deaths Reported

9

of 116 reports

Death-coded share of reports

7.8%

Above-median death-coded share

Avg Age at Report

7.4 yr

5.5 kg avg weight

Death-Coded Outcome Share

Bombay death-coded reports 7.8%
Cross-breed median

7.8% of 116 bombay reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Bombay's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

8% 74th percentile Higher share than 74% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Bombay 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 5.5 kg (12.1 lbs)

Top Reported Reactions

Application site hair loss 17
Vomiting 16
Lack of efficacy (ectoparasite) - flea 10
Anorexia 9
Lethargy (see also Central nervous system depression in 'Neurological') 9
Behavioural disorder NOS 8
Application site alopecia 8
Not eating 8

Most Referenced Drugs

Fluralaner Spot-On Solution 17
Selamectin;Sarolaner 16
Spinosad 12
Frunevetmab 12
Nitenpyram 11
Buprenorphine 7
Selamectin 6
Robenacoxib 6

Outcome Breakdown

Ongoing
41 (35.3%)
Outcome Unknown
39 (33.6%)
Recovered/Normal
26 (22.4%)
Euthanized
5 (4.3%)
Died
4 (3.4%)
Recovered with Sequela
1 (0.9%)

Gender Distribution

Male 72 (62.1%)
Female 42 (36.2%)
Unknown 2 (1.7%)

Reports by Year

Year Reports Trend
2012 4
2013 4
2014 2
2015 3
2016 7
2017 5
2018 9
2019 4
2020 5
2021 11
2022 3
2023 13
2024 21
2025 23
2026 2

Bombay: high death-coded share in the FDA CVM extract

Signature read: Bombay's 7.8% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Bombay sits at #226 of 510 by report volume among all breeds and #25 of 55 among cat breeds, with 116 reports and 9 (7.8%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #72 of 275. Mean age at report: 7.4 years, average weight 5.5 kg (12.1 lbs).

Top reported signs: Application site hair loss (17), Vomiting (16), Lack of efficacy (ectoparasite) - flea (10). Most-referenced drug: Fluralaner Spot-On Solution (17 reports), followed by Selamectin;Sarolaner (16) and Spinosad (12).

Outcome coding on 116 status-recorded reports is dominated by Ongoing (35.3%). Annual submissions ranged 2-2,026 across 15 years on file.

Cat Breeds With a Similar Report Volume

Showing 6 of 54 cat breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Bombay, both outside the Cat family so the neighborhoods are not species containment (the similar-volume list above stays within species).

What to do with this cat

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Bombay?
There are 116 adverse event reports involving Bombay in the FDA database, of which 9 were death-coded (7.8% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Bombay ranks #226 of 510 by report volume among all breeds PlainBreed indexes (#25 of 55 among cat breeds).
Where does Bombay sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Bombay is #226 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Cat, it is #25 of 55. Among breeds with at least 50 reports, its death-coded share ranks #72 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Bombay?
The most commonly reported adverse reactions for Bombay are Application site hair loss (17 reports), Vomiting (16 reports), Lack of efficacy (ectoparasite) - flea (10 reports), Anorexia (9 reports), Lethargy (see also Central nervous system depression in 'Neurological') (9 reports).
What drugs are most frequently associated with Bombay adverse events?
The drugs most frequently referenced in Bombay adverse event reports are Fluralaner Spot-On Solution (17 reports), Selamectin;Sarolaner (16 reports), Spinosad (12 reports), Frunevetmab (12 reports), Nitenpyram (11 reports).
What is the average age of Bombay in adverse event reports?
The average age of Bombay at the time of adverse event reports is 7.4 years, with an average weight of 5.5 kg (12.1 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Bombay (Cat), extract as of July 2026 extract. 116 reports · 9 death-coded (7.8% of reports, not a mortality rate) · #226 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →